NO812432L - Fremgangsmaate for fremstilling av terapeutisk aktive pyrimidin-2-on-derivater. - Google Patents

Fremgangsmaate for fremstilling av terapeutisk aktive pyrimidin-2-on-derivater.

Info

Publication number
NO812432L
NO812432L NO812432A NO812432A NO812432L NO 812432 L NO812432 L NO 812432L NO 812432 A NO812432 A NO 812432A NO 812432 A NO812432 A NO 812432A NO 812432 L NO812432 L NO 812432L
Authority
NO
Norway
Prior art keywords
group
formula
compound
het
pyrimidin
Prior art date
Application number
NO812432A
Other languages
English (en)
Norwegian (no)
Inventor
Gordon Hanley Phillipps
Christopher Williamson
Ian Philip Steeples
Brian Macdonald Bain
Raymond Andrew Borella
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of NO812432L publication Critical patent/NO812432L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
NO812432A 1980-07-15 1981-07-15 Fremgangsmaate for fremstilling av terapeutisk aktive pyrimidin-2-on-derivater. NO812432L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8023083 1980-07-15

Publications (1)

Publication Number Publication Date
NO812432L true NO812432L (no) 1982-01-18

Family

ID=10514776

Family Applications (1)

Application Number Title Priority Date Filing Date
NO812432A NO812432L (no) 1980-07-15 1981-07-15 Fremgangsmaate for fremstilling av terapeutisk aktive pyrimidin-2-on-derivater.

Country Status (12)

Country Link
US (1) US4650800A (de)
EP (1) EP0044705B1 (de)
JP (1) JPS5740483A (de)
AT (1) ATE10256T1 (de)
AU (1) AU7300281A (de)
CA (1) CA1159830A (de)
DE (1) DE3167186D1 (de)
DK (1) DK315381A (de)
ES (1) ES503985A0 (de)
NO (1) NO812432L (de)
NZ (1) NZ197715A (de)
ZA (1) ZA814843B (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8420610D0 (en) * 1984-08-14 1984-09-19 Glaxo Group Ltd Chemical compounds
JPH0679095B2 (ja) * 1986-04-03 1994-10-05 旭硝子株式会社 プラスチツククラツド光伝送フアイバ−
RU2102985C1 (ru) * 1995-11-10 1998-01-27 Владимир Константинович Васильев Способ подавления гиперактивных клеток

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1561290A (en) * 1975-10-16 1980-02-20 Nyegaard & Co As Pyrimid - 2 - ones
ES498337A0 (es) * 1980-01-07 1982-06-01 Nyegaard & Co As Un procedimiento para la preparacion de 5-halo-pirimidin-2- onas

Also Published As

Publication number Publication date
ES8300750A1 (es) 1982-11-01
ZA814843B (en) 1983-02-23
DE3167186D1 (en) 1984-12-20
EP0044705A1 (de) 1982-01-27
AU7300281A (en) 1982-01-21
JPS5740483A (en) 1982-03-06
US4650800A (en) 1987-03-17
NZ197715A (en) 1984-12-14
ATE10256T1 (de) 1984-11-15
DK315381A (da) 1982-01-16
CA1159830A (en) 1984-01-03
ES503985A0 (es) 1982-11-01
EP0044705B1 (de) 1984-11-14

Similar Documents

Publication Publication Date Title
AU2019201352B2 (en) Bromodomain inhibitors
ES2855135T3 (es) Amidas heterocíclicas como inhibidores de quinasa
RU2129549C1 (ru) Производные пиримидина и способы их получения
US3758476A (en) 2-(thienyl-3'-amino)-1,3-diazacycloalkenes
CA2844128C (en) Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof
BRPI0720525A2 (pt) Inibidores de quinase mapk/erk
GB2449293A (en) Compounds having Hsp90 inhibitory activity
BR112012002251B1 (pt) processo para a fabricação do composto de fórmula (1), compostos, composição, método analítico e processo para a fabricação do composto (i)
JPH0242074A (ja) ベンゾピラン誘導体およびその製造法
BR112019024376A2 (pt) composto de fórmula geral (i), ou sais farmaceuticamente aceitáveis destes, composição farmacêutica e uso dos compostos ou sais farmaceuticamente aceitáveis destes
BRPI0717374A2 (pt) Inibidores de mapk/erk quinase
FI59253B (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara 4-hydroxi-2h-tieno(2,3-e) och (3,4-e)-1,2-tiazin-3-karboxamid-1,1-dioxid-derivat
MX2012005189A (es) Inhibidores de ire-1-alfa.
EP0044704B1 (de) Substituierte Pyrimidin-2-one, ihre Salze, Verfahren zu deren Herstellung und diese enthaltende Zusammensetzungen
NO810024L (no) Fremgangsmaate for fremstilling av farmasoeytisk aktive pyrimidinonderivater.
ES2968388T3 (es) Forma cristalina D del compuesto pirazina-2(1H)-cetona y método para su preparación
NO812432L (no) Fremgangsmaate for fremstilling av terapeutisk aktive pyrimidin-2-on-derivater.
JPH0249784A (ja) 三環式縮合ピリミジン誘導体
US3636041A (en) 4 5-dihydro-7h-thieno(2 3-c)thiopyrans
NO820291L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive alkanolaminderivater
GB2080301A (en) Substituted Pyrimidin-2-ones, the Salts thereof, Processes for their Preparation and Pharmaceutical Compositions Containing them
NO161440B (no) Analogifremgangsmaate for fremstilling av fysiologisk aktive pyrimidin-2-oner.
JP2989865B2 (ja) ピロロキノリン誘導体、そのエステルおよびその塩
Pirotte et al. Pyridothiadiazinedioxides structurally related to quinazolinones cholecystokinin/gastrin receptor ligands: synthesis and biological evaluation
JP2966893B2 (ja) 新規キノロン―3―カルバルデヒド誘導体およびその塩